12-132643881-C-T

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_006231.4(POLE):​c.4246G>A​(p.Ala1416Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000133 in 1,614,154 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00033 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

POLE
NM_006231.4 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:5

Conservation

PhyloP100: 3.27
Variant links:
Genes affected
POLE (HGNC:9177): (DNA polymerase epsilon, catalytic subunit) This gene encodes the catalytic subunit of DNA polymerase epsilon. The enzyme is involved in DNA repair and chromosomal DNA replication. Mutations in this gene have been associated with colorectal cancer 12 and facial dysmorphism, immunodeficiency, livedo, and short stature. [provided by RefSeq, Sep 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0065257847).
BP6
Variant 12-132643881-C-T is Benign according to our data. Variant chr12-132643881-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 240508.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=3, Benign=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
POLENM_006231.4 linkuse as main transcriptc.4246G>A p.Ala1416Thr missense_variant 33/49 ENST00000320574.10 NP_006222.2 Q07864

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
POLEENST00000320574.10 linkuse as main transcriptc.4246G>A p.Ala1416Thr missense_variant 33/491 NM_006231.4 ENSP00000322570.5 Q07864

Frequencies

GnomAD3 genomes
AF:
0.000302
AC:
46
AN:
152168
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000820
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000243
AC:
61
AN:
251414
Hom.:
0
AF XY:
0.000221
AC XY:
30
AN XY:
135894
show subpopulations
Gnomad AFR exome
AF:
0.000738
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00397
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000112
AC:
164
AN:
1461868
Hom.:
0
Cov.:
32
AF XY:
0.000113
AC XY:
82
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.000956
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00344
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000126
Gnomad4 OTH exome
AF:
0.000397
GnomAD4 genome
AF:
0.000335
AC:
51
AN:
152286
Hom.:
1
Cov.:
33
AF XY:
0.000389
AC XY:
29
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.000938
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00231
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000218
Hom.:
0
Bravo
AF:
0.000397
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000231
AC:
28
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Uncertain significance, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The POLE p.Ala1416Thr variant was not reported in the literature nor was it identified in the following databases: Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs146711942) and ClinVar (classified as uncertain significance by GeneDx, Invitae, Quest Diagnostics Nichols Institute San Juan Capistrano and Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago, and as likely benign by Ambry Genetics). The variant was identified in control databases in 71 of 268310 chromosomes at a frequency of 0.0002646 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Ashkenazi Jewish in 41 of 9856 chromosomes (freq: 0.00416), African in 20 of 23610 chromosomes (freq: 0.000847), Other in 4 of 6702 chromosomes (freq: 0.000597), East Asian in 1 of 19250 chromosomes (freq: 0.000052) and European (non-Finnish) in 5 of 118166 chromosomes (freq: 0.000042), but was not observed in the Latino, European (Finnish), or South Asian populations. The p.Ala1416 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Likely benign, criteria provided, single submitterclinical testingGeneDxMar 28, 2021This variant is associated with the following publications: (PMID: 28873162) -
Hereditary cancer-predisposing syndrome Benign:2
Likely benign, criteria provided, single submittercurationSema4, Sema4Jun 19, 2021- -
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 11, 2021This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoMay 13, 2017- -
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCenter for Genomics, Ann and Robert H. Lurie Children's Hospital of ChicagoSep 12, 2018POLE NM_006231.3 exon 33 p.Ala1416Thr (c.4246G>A): This variant has been reported in the literature in at least 1 individual with unspecified advanced cancer (Mandelker 2017 PMID:28873162). This variant is present in 0.4% (47/10152) of Ashkenazi Jewish alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/12-133220467-C-T) and is present in ClinVar (Variation ID:240508). This variant amnio acid Threonine (Thr) is present in >40 species, including mammals. This suggests that this variant may not impact the protein. Additional computational prediction tools also do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
Colorectal cancer, susceptibility to, 12;C3554576:Facial dysmorphism-immunodeficiency-livedo-short stature syndrome;C5193036:Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCenter for Genomics, Ann and Robert H. Lurie Children's Hospital of ChicagoMar 30, 2021POLE NM_006231.3 exon 33 p.Ala1416Thr (c.4246G>A): This variant has been reported in the literature in at least 1 individual with unspecified advanced cancer (Mandelker 2017 PMID:28873162). This variant is present in 0.4% (47/10152) of Ashkenazi Jewish alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/12-133220467-C-T) and is present in ClinVar (Variation ID:240508). This variant amnio acid Threonine (Thr) is present in >40 species, including mammals. This suggests that this variant may not impact the protein. Additional computational prediction tools also do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
POLE-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJun 07, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
16
DANN
Benign
0.43
DEOGEN2
Benign
0.061
T;.
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.70
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Benign
0.78
T;T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.0065
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.5
L;.
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.67
N;N
REVEL
Benign
0.064
Sift
Benign
0.66
T;T
Sift4G
Benign
0.73
T;T
Polyphen
0.0010
B;B
Vest4
0.071
MVP
0.23
MPC
0.18
ClinPred
0.015
T
GERP RS
1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Varity_R
0.016
gMVP
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs146711942; hg19: chr12-133220467; API